Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Shares (2016)

Enanta Pharmaceuticals (ENTA) has disclosed Preferred Shares for 2 consecutive years, with $158000.0 as the latest value for Q2 2016.

  • For the quarter ending Q2 2016, Preferred Shares changed N/A year-over-year to $158000.0, compared with a TTM value of $158000.0 through Jun 2016, changed N/A, and an annual FY2015 reading of $163000.0, changed N/A over the prior year.
  • Preferred Shares was $158000.0 for Q2 2016 at Enanta Pharmaceuticals, up from $156000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $163000.0 in Q3 2015 and bottomed at $156000.0 in Q1 2016.